CBL Patras is a CDMO of peptides based in Greece. Direct manufacturer. Founded 1990. Key products include peptide starting materials, peptide intermediates.
Listing reviewed September 2026.
Greek supplier of peptide starting materials and intermediates. Operates 10,000+ sqm facility producing high-purity peptide building blocks. Serves international pharma and biotech.
Directory assessment: CBL Patras is listed as a CDMO in the peptide supply chain, serving Europe markets from Greece. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.